Can The Rally Continue?, The COVID-19 And Vaccine Effect On Stocks, And A Tough Day For Alibaba And Chinese Stocks
Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks and whether they can maintain their upward momentum. The anchors reacted to a new note from Goldman Sachs Chief U.S. Equity Strategist David Kostin, who is raising his year-end S&P 500 price target to 3,700. They also explored buying strategies when it comes to value versus growth and where COVID-19 and vaccines come into play. Also in focus: President Trump’s refusal to concede the 2020 election and what that means for the markets, Alibaba shares falling after Chinese regulators drafted anti-monopoly guidelines, and what’s driving a strong session for chip stocks.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Carl Quintanilla, Jim Cramer and David Faber discussed the road ahead for stocks and whether they can maintain their upward momentum. The anchors reacted to a new note from
Goldman Sachs Chief U.S. Equity Strategist David Kostin, who is raising his year-end S&P 500 price target to 3,700. They also explored buying strategies when it comes to value versus growth and where
COVID-19 and vaccines come into play. Also in focus: President Trump’s refusal to concede the 2020 election and what that means for the markets, Alibaba shares falling after Chinese regulators drafted anti-monopoly guidelines, and what’s driving a strong session for chip stocks.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.